P523: THE COMPARISON OF VFLAI, FLAI AND 3 + 7 REGIMENS BY MULTILEVEL PROPENSITY SCORE WEIGHTING HIGHLIGHTS THE BENEFIT OF THE ADDITION OF VENETOCLAX IN NO LOW‐RISK AML TREATED IN GIMEMA TRIALS AND REAL WORLD.

Details

Language :

English

ISSN :

25729241

Volume :

7

Database :

Complementary Index

Journal :

HemaSphere

Publication Type :

Academic Journal

Accession number :

176093909

Full Text :

https://doi.org/10.1097/01.HS9.0000969000.00342.16